Clinical Trials Browser

Phase 1/2 × Dysplastic Nevus Syndrome × Betulinic Acid × Clear all

NCT00346502 2021-06-28

Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)

Phase 1/2 Withdrawn

Dysplastic Nevus Syndrome